文献
J-GLOBAL ID:202202272906103631
整理番号:22A0295339
KCNQ2関連自己制限てんかんのマウスモデルにおけるエスリカルバゼピンアセタートのin vitroおよびin vivo抗てんかん効果【JST・京大機械翻訳】
In vitro and in vivo anti-epileptic efficacy of eslicarbazepine acetate in a mouse model of KCNQ2-related self-limited epilepsy
著者 (15件):
Monni Laura
(Clinical and Experimental Epileptology, Department of Neurology, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin, Berlin, Germany)
,
Monni Laura
(NeuroCure Clinical Research Centre, Berlin Institute of Health at Charite-Universitaetsmedizin Berlin, Berlin, Germany)
,
Kraus Larissa
(Clinical and Experimental Epileptology, Department of Neurology, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin, Berlin, Germany)
,
Kraus Larissa
(Life Sciences Institute, Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada)
,
Dipper-Wawra Matthias
(Clinical and Experimental Epileptology, Department of Neurology, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin, Berlin, Germany)
,
Dipper-Wawra Matthias
(Epilepsy-Center Berlin-Brandenburg, Institute for Diagnostics of Epilepsy, Berlin, Germany)
,
Soares-da-Silva Patricio
(Division of Research and Development, BIAL - Portela & CA S. A, da Siderurgia Nacional, Sao Mamede do Coronado, Portugal)
,
Soares-da-Silva Patricio
(Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University Porto, Porto, Portugal)
,
Soares-da-Silva Patricio
(MedInUP, Centre for Drug Discovery and Innovative Medicines, University Porto, Porto, Portugal)
,
Maier Nikolaus
(Neuroscience Research Centre, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin, Berlin, Germany)
,
Schmitz Dietmar
(Neuroscience Research Centre, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin, Berlin, Germany)
,
Holtkamp Martin
(Clinical and Experimental Epileptology, Department of Neurology, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin, Berlin, Germany)
,
Holtkamp Martin
(Epilepsy-Center Berlin-Brandenburg, Institute for Diagnostics of Epilepsy, Berlin, Germany)
,
Fidzinski Pawel
(Clinical and Experimental Epileptology, Department of Neurology, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin, Berlin, Germany)
,
Fidzinski Pawel
(NeuroCure Clinical Research Centre, Berlin Institute of Health at Charite-Universitaetsmedizin Berlin, Berlin, Germany)
資料名:
British Journal of Pharmacology
(British Journal of Pharmacology)
巻:
179
号:
1
ページ:
84-102
発行年:
2022年
JST資料番号:
B0334A
ISSN:
0007-1188
CODEN:
BJPCB
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)